Amgen IncNASDAQ:AMGN
- LAST PRICE283.2900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots280.5900/ 1
- Ask / Lots284.8800/ 1
- Open / Previous Close285.8400 / 283.2900
- Day Range
- 52 Week Range
- Volume2,479,398
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 53866 | 285.61 |
| 09:33 ET | 4531 | 285.76 |
| 09:35 ET | 14953 | 286.69 |
| 09:37 ET | 9896 | 286.3 |
| 09:39 ET | 8600 | 287.19 |
| 09:42 ET | 4664 | 286.89 |
| 09:44 ET | 8973 | 286 |
| 09:46 ET | 8173 | 285.92 |
| 09:48 ET | 6422 | 286.08 |
| 09:50 ET | 7498 | 286.55 |
| 09:51 ET | 8200 | 286.9 |
| 09:53 ET | 6571 | 286.95 |
| 09:55 ET | 10427 | 286.83 |
| 09:57 ET | 4537 | 286.95 |
| 10:00 ET | 12017 | 286.705 |
| 10:02 ET | 11943 | 286.295 |
| 10:04 ET | 11992 | 286.26 |
| 10:06 ET | 5661 | 286.52 |
| 10:08 ET | 6811 | 286.355 |
| 10:09 ET | 8466 | 286.47 |
| 10:11 ET | 7960 | 286.21 |
| 10:13 ET | 7580 | 286.07 |
| 10:15 ET | 2256 | 286.1 |
| 10:18 ET | 4582 | 286.41 |
| 10:20 ET | 2330 | 286.39 |
| 10:22 ET | 12952 | 286.73 |
| 10:24 ET | 2923 | 286.9 |
| 10:26 ET | 7099 | 286.56 |
| 10:27 ET | 2271 | 286.37 |
| 10:29 ET | 5243 | 285.82 |
| 10:31 ET | 15426 | 285.852 |
| 10:33 ET | 4606 | 286.125 |
| 10:36 ET | 3143 | 285.97 |
| 10:38 ET | 3979 | 286.05 |
| 10:40 ET | 6211 | 285.935 |
| 10:42 ET | 3274 | 285.7 |
| 10:44 ET | 3111 | 285.6 |
| 10:45 ET | 4060 | 286 |
| 10:49 ET | 6956 | 285.7 |
| 10:51 ET | 3440 | 285.525 |
| 10:54 ET | 2550 | 285.64 |
| 10:56 ET | 7024 | 285.69 |
| 10:58 ET | 5244 | 285.64 |
| 11:00 ET | 2941 | 285.71 |
| 11:02 ET | 1800 | 285.755 |
| 11:03 ET | 9481 | 285.805 |
| 11:05 ET | 2400 | 286.02 |
| 11:07 ET | 4641 | 285.82 |
| 11:09 ET | 7235 | 285.69 |
| 11:12 ET | 3251 | 285.86 |
| 11:14 ET | 1866 | 285.62 |
| 11:16 ET | 8800 | 285.07 |
| 11:18 ET | 4088 | 285.43 |
| 11:20 ET | 1348 | 285.185 |
| 11:21 ET | 2127 | 285.56 |
| 11:23 ET | 3079 | 285.68 |
| 11:25 ET | 1361 | 285.26 |
| 11:27 ET | 2483 | 285.35 |
| 11:30 ET | 1314 | 285.41 |
| 11:32 ET | 1709 | 285.49 |
| 11:34 ET | 2354 | 285.5701 |
| 11:36 ET | 1767 | 285.565 |
| 11:38 ET | 2551 | 285.555 |
| 11:39 ET | 3500 | 285.43 |
| 11:41 ET | 4856 | 285.265 |
| 11:43 ET | 2470 | 285.3399 |
| 11:45 ET | 1325 | 285.3279 |
| 11:48 ET | 4083 | 285.17 |
| 11:50 ET | 2275 | 285.23 |
| 11:52 ET | 700 | 285.21 |
| 11:54 ET | 2320 | 284.92 |
| 11:56 ET | 700 | 285.02 |
| 11:57 ET | 3608 | 285.3 |
| 11:59 ET | 3029 | 285.165 |
| 12:01 ET | 4400 | 285.19 |
| 12:03 ET | 2790 | 285.11 |
| 12:06 ET | 2000 | 284.98 |
| 12:08 ET | 2260 | 285.03 |
| 12:10 ET | 2200 | 284.835 |
| 12:12 ET | 1350 | 284.61 |
| 12:14 ET | 1324 | 284.685 |
| 12:15 ET | 7170 | 284.59 |
| 12:17 ET | 3650 | 284 |
| 12:19 ET | 1200 | 283.99 |
| 12:21 ET | 5404 | 284.16 |
| 12:24 ET | 3651 | 284.06 |
| 12:26 ET | 2951 | 284.04 |
| 12:28 ET | 1806 | 283.89 |
| 12:30 ET | 500 | 283.86 |
| 12:32 ET | 2133 | 283.635 |
| 12:33 ET | 2446 | 283.6044 |
| 12:35 ET | 1110 | 283.565 |
| 12:37 ET | 704 | 283.4 |
| 12:39 ET | 1532 | 283.42 |
| 12:42 ET | 5790 | 283.78 |
| 12:44 ET | 1454 | 283.66 |
| 12:46 ET | 1646 | 283.89 |
| 12:48 ET | 3112 | 284.05 |
| 12:50 ET | 500 | 284.18 |
| 12:51 ET | 2333 | 284.255 |
| 12:53 ET | 4149 | 284.36 |
| 12:55 ET | 2522 | 284.23 |
| 12:57 ET | 3904 | 284.42 |
| 01:00 ET | 2593 | 284.535 |
| 01:02 ET | 2308 | 284.265 |
| 01:04 ET | 9715 | 284.205 |
| 01:06 ET | 5245 | 283.8 |
| 01:08 ET | 2970 | 283.56 |
| 01:09 ET | 7471 | 283.445 |
| 01:11 ET | 400 | 283.26 |
| 01:13 ET | 11691 | 283.005 |
| 01:15 ET | 2690 | 283.0548 |
| 01:18 ET | 800 | 283.15 |
| 01:20 ET | 2743 | 282.9915 |
| 01:22 ET | 5739 | 282.87 |
| 01:24 ET | 3526 | 282.82 |
| 01:26 ET | 13832 | 282.525 |
| 01:27 ET | 9472 | 282.69 |
| 01:29 ET | 13620 | 282.61 |
| 01:31 ET | 18377 | 282.48 |
| 01:33 ET | 5360 | 282.37 |
| 01:36 ET | 17847 | 282.09 |
| 01:38 ET | 9083 | 282.14 |
| 01:40 ET | 3219 | 281.89 |
| 01:42 ET | 9869 | 282.17 |
| 01:44 ET | 5045 | 282.11 |
| 01:45 ET | 3368 | 281.96 |
| 01:47 ET | 5161 | 282.01 |
| 01:49 ET | 3702 | 282.08 |
| 01:51 ET | 1492 | 281.985 |
| 01:54 ET | 6560 | 281.93 |
| 01:56 ET | 10116 | 281.89 |
| 01:58 ET | 2394 | 281.74 |
| 02:00 ET | 2400 | 281.95 |
| 02:02 ET | 11945 | 282.08 |
| 02:03 ET | 16863 | 282.53 |
| 02:05 ET | 3029 | 282.62 |
| 02:07 ET | 3232 | 282.62 |
| 02:09 ET | 1900 | 282.65 |
| 02:12 ET | 5083 | 282.3123 |
| 02:14 ET | 4958 | 282.46 |
| 02:16 ET | 1462 | 282.24 |
| 02:18 ET | 3101 | 283.03 |
| 02:20 ET | 1300 | 283.3 |
| 02:21 ET | 1213 | 283.34 |
| 02:23 ET | 5104 | 283.28 |
| 02:25 ET | 2562 | 283.42 |
| 02:27 ET | 2417 | 283.15 |
| 02:30 ET | 2477 | 283.075 |
| 02:32 ET | 1702 | 283.09 |
| 02:34 ET | 2900 | 282.77 |
| 02:36 ET | 23390 | 283.24 |
| 02:38 ET | 900 | 283.33 |
| 02:39 ET | 1937 | 283.2 |
| 02:41 ET | 2427 | 283.34 |
| 02:43 ET | 2277 | 283.44 |
| 02:45 ET | 1227 | 283.22 |
| 02:48 ET | 1639 | 283.04 |
| 02:50 ET | 2009 | 283.14 |
| 02:52 ET | 847 | 283.15 |
| 02:54 ET | 1865 | 283.02 |
| 02:56 ET | 1100 | 283.12 |
| 02:57 ET | 1202 | 282.99 |
| 02:59 ET | 3061 | 282.96 |
| 03:01 ET | 5547 | 283.15 |
| 03:03 ET | 11662 | 282.93 |
| 03:06 ET | 2336 | 282.9605 |
| 03:08 ET | 2124 | 282.59 |
| 03:10 ET | 3937 | 282.575 |
| 03:12 ET | 4014 | 282.56 |
| 03:14 ET | 3568 | 282.42 |
| 03:15 ET | 4783 | 282.33 |
| 03:17 ET | 8009 | 282.42 |
| 03:19 ET | 11650 | 282.28 |
| 03:21 ET | 6300 | 282.3 |
| 03:24 ET | 5369 | 282.57 |
| 03:26 ET | 2772 | 282.68 |
| 03:28 ET | 3408 | 282.31 |
| 03:30 ET | 3788 | 282.37 |
| 03:32 ET | 6669 | 282.645 |
| 03:33 ET | 5759 | 282.815 |
| 03:35 ET | 6100 | 282.965 |
| 03:37 ET | 5293 | 283.0757 |
| 03:39 ET | 3917 | 283.1389 |
| 03:42 ET | 7794 | 283.0692 |
| 03:44 ET | 10192 | 283.18 |
| 03:46 ET | 6255 | 283.12 |
| 03:48 ET | 11478 | 283.07 |
| 03:50 ET | 6835 | 282.99 |
| 03:51 ET | 23268 | 282.83 |
| 03:53 ET | 13928 | 282.89 |
| 03:55 ET | 23891 | 282.92 |
| 03:57 ET | 24960 | 283.13 |
| 04:00 ET | 411003 | 283.29 |
Yesterday
UPDATE 1-Unsubstantiated price hikes drove U.S. drug spending up $805 mln in 2021-report, from 12 hours ago by Thomson Reuters
12 hours ago by Thomson ReutersOppenheimer Adjusts Amgen Price Target to $310 From $300, Maintains Outperform Rating, from 13 hours ago by MT Newswires
13 hours ago by MT NewswiresUPDATE 1-Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients, from 1:42AM ET on Tuesday Dec 06, 2022 by Thomson Reuters
1:42AM ET on Tuesday Dec 06, 2022 by Thomson Reuters
Dec 5, 2022
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients, from 6:05PM ET on Monday Dec 05, 2022 by Thomson Reuters
6:05PM ET on Monday Dec 05, 2022 by Thomson ReutersBUZZ-U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba, from 2:02PM ET on Monday Dec 05, 2022 by Thomson Reuters
2:02PM ET on Monday Dec 05, 2022 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 152.0B | 22.7x | +0.08% |
Gilead Sciences Inc | 110.3B | 33.3x | -13.08% |
Sanofi SA | 114.3B | 18.2x | +7.84% |
Bristol-Myers Squibb Co | 171.6B | 26.1x | +3.27% |
AstraZeneca PLC | 214.4B | 105.0x | -50.95% |
HALEON PLC | 33.5B | 19.5x | --- |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
- Executive Vice President - Human Resources
- Lori Johnston
- Executive Vice President - Global Commercial Operations
- Murdo Gordon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $151.2B |
|---|---|
Revenue (TTM) | $26.3B |
Shares Outstanding | 533.6M |
Dividend Yield | 2.74% |
Annual Dividend Rate | 7.7600 USD |
Ex-Dividend Date | 11-16-22 |
Pay Date | 12-08-22 |
Beta | 0.65 |
EPS | $12.48 |
Book Value | $12.00 |
P/E Ratio | 22.7x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | 14.8x |
Operating Margin | 36.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
